OBSIDIO™ Conformable Embolic (M0013972101010)
Device, Vascular, For Promoting Embolization. 510(k) K253376, from Boston Scientific Corporation (Maple Grove, MN). Product code KRD, class 2.
As of Nov 18, 2026, K253376 is an FDA 510(k) held by Boston Scientific Corporation, substantially equivalent on Oct 30, 2025 after 30 days, with no recalls tied to it in FDA's recall database.
- Review time: 30 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe OBSIDIO™ Conformable Embolic is indicated for use in the embolization of: • Hypervascular tumors • Blood vessels to occlude blood flow for controlling bleeding/hemorrhaging in the peripheral vasculature
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- OBSIDIO™ Conformable EmbolicK242507 · Boston Scientific · Oct 3, 2024
Other KRD clearances
The newest 510(k)s for the same product code; their median review was 70 days; see every KRD device- LOBO Vascular Occlusion SystemK262798 · Okami Medical, Inc. · Oct 6, 2026
- UniPearls® Embolic MicrospheresK252812 · Suzhou Haowei Medical Technology Co., Ltd. · Jul 31, 2026
- OBSIDIO Conformable EmbolicK261488 · Boston Scientific Corporation · Jul 24, 2026
- Concerto Versa™ Detachable CoilK261866 · Medtronic, Inc. · Jun 24, 2026
- HARBOR Occlusion DeviceK260635 · Nuvascular, Inc. · Jun 12, 2026
- LOBO Vascular Occlusion SystemK260508 · Okami Medical, Inc. · Apr 10, 2026
- Concerto Versa™ Detachable CoilK253511 · Medtronic, Inc. · Jan 14, 2026
- Tembo Embolic SystemK253677 · Instylla, Inc. · Dec 15, 2025
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Sep 30, 2025
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files